Holen Sie sich die Stockscreener-App
6.00
6.09%
0.3445
Schlusskurs vom Vortag:
$5.6555
Offen:
$5.74
24-Stunden-Volumen:
21,842
Relative Volume:
1.87
Marktkapitalisierung:
$73.30M
Einnahmen:
$291.44M
Nettoeinkommen (Verlust:
$-44.17M
KGV:
-1.4286
EPS:
-4.2
Netto-Cashflow:
-
1W Leistung:
+3.27%
1M Leistung:
+6.29%
6M Leistung:
+12.78%
1J Leistung:
+34.23%
1-Tages-Spanne:
$5.5803
$6.00
1-Wochen-Bereich:
$5.5803
$6.00
52-Wochen-Spanne:
$2.85
$7.838
Prenetics Global Limited Stock (PRE) Company Profile
Firmenname
Prenetics Global Limited
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PRE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRE
Prenetics Global Limited
|
6.00 | 73.30M | 291.44M | -44.17M | 0 | -4.20 |
|
TMO
Thermo Fisher Scientific Inc
|
573.06 | 219.20B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
244.11 | 176.31B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
152.57 | 43.57B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
205.69 | 37.33B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
427.33 | 34.99B | 3.84B | 866.24M | 792.60M | 10.37 |
Prenetics Global Limited Stock (PRE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
Prenetics Global Limited Aktie (PRE) Neueste Nachrichten
Prenetics Unveils IM8 to U.S. Consumers with Co-Founding Partner David Beckham - GlobeNewswire
Prenetics Global (NASDAQ:PRE) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat
Prenetics’ IM8 Achieves Prestigious NSF Certified for Sport® for Daily Ultimate Essentials - GlobeNewswire
When (PRE) Moves Investors should Listen - Stock Traders Daily
Financial Comparison: Prenetics Global (NASDAQ:PRE) and 10x Genomics (NASDAQ:TXG) - Defense World
Where are the Opportunities in (PRE) - Stock Traders Daily
Short Interest in Prenetics Global Limited (NASDAQ:PRE) Rises By 23.6% - MarketBeat
Prenetics Global (NASDAQ:PRE) Trading Down 1.6%What's Next? - MarketBeat
Prenetics Global (NASDAQ:PRE) Shares Down 1.6% – Here’s Why - Defense World
Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements - The Manila Times
Prenetics’ IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements - GlobeNewswire
Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 32% Share Price Bounce - Simply Wall St
Precision Nutrition Industry Assessment and Forecast to 2029: Revenues Anticipated to Reach $12.9 BillionCase Study Analysis Featuring 23AndMe, Genesis Healthcare Co, and Viome Life Sciences - GlobeNewswire
Prenetics Global Announces 2024 Annual General Meeting - TipRanks
iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024 - Financial Content
Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services - The Manila Times
Prenetics’ IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services - GlobeNewswire
Prenetics Announces Participation in December Investor Conferences - The Manila Times
Prenetics Global CEO to Present at iAccess Alpha Conference; Set for ROTH Deer Valley Event - StockTitan
Contrasting Prenetics Global (NASDAQ:PRE) and Standard BioTools (NASDAQ:LAB) - Defense World
Prenetics Global Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Prenetics Announces Third Quarter 2024 Financial Results - The Manila Times
Prenetics Reports Strong Growth with New Launches - TipRanks
Prenetics Announces Third Quarter 2024 Financial Results | DigitalMore.co - Digital More
Prenetics Global Q3 Revenue Surges 59% to $7.8M, Secures $30M Tencent Investment | PRE Stock News - StockTitan
Prenetics Announces the Launch of IM8 Health - Marketscreener.com
MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health - The Bakersfield Californian
Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health - The Manila Times
Prenetics and David Beckham launch IM8 brand with two health and wellness supplements - Yahoo Finance
Prenetics Global And 2 Other US Penny Stocks To Watch - Yahoo Finance
Sidoti Events, LLC's Virtual November Micro-Cap Conference - WICZ
PREPrenetics Global Limited Latest Stock News & Market Updates - StockTitan
Ellington Financial Announces Full Redemption of Series E Preferred Stock for $24.4M | PRE Stock News - StockTitan
Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference - The Manila Times
Genetic Genealogy Market Expected to Reach $1.69 Billion by 2031, Growing at 8.3% CAGR - WhaTech
Prenetics Acquires ACT Genomics; First M&A Deal since IPO, Set to Expand Footprint in Cancer Genomics - AsiaOne
Tencent invests $30M in Insighta to progress cancer diagnostics platform - BioWorld Online
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating, Business Wires News - AsiaOne
Tencent invests $30m into HK-based early cancer detection firm - FinanceAsia
Prenetics (PRE) Stock Soars After Key Equity Announcement - Stocks Telegraph
Prenetics Announces Tencent's US$30 Million Investment in Insighta, Strengthening Strategic Partnership for - Digital More
Prenetics Announces Tencent's US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection - The Manila Times
Prenetics announces Tencent's US$30 Million investment in Insighta - Vietnam Investment Review
Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic - The Bakersfield Californian
Prenetics Announces Tencent’s US$30 Million Investment in Insighta, Strengthening Strategic Partnership for AI-Driven Early Cancer Detection - StockTitan
Prenetics Global Limited's (NASDAQ:PRE) Earnings Haven't Escaped The Attention Of Investors - Simply Wall St
Prenetics Global Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Simply Wall St
Prenetics Announces Second Quarter 2024 Financial Results - The Manila Times
Prenetics Global Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
Finanzdaten der Prenetics Global Limited-Aktie (PRE)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):